American College of Clinical Pharmacy
      Search      Cart

Global Health PRN Focus Session -- Turning the Tide of Noncommunicable Diseases (NCDs) in Developing Countries

Sunday, October 08, 2017 from 2:15 PM to 3:45 PM MST at Phoenix Convention Center North Building Street Level: Meeting Room 124

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-142-L04-P
Activity Type: A Knowledge-Based Activity

  • Harleen Singh, Pharm.D.Moderator: Harleen Singh, Pharm.D.
    Associate Professor, Oregon State University, Portland, Oregon

Noncommunicable Diseases: Global Trends and Initiatives
2:15 PM

  • Sonak Pastakia, Pharm.D., MPH, BCPSSpeaker: Sonak Pastakia, Pharm.D., MPH, BCPS
    Associate Professor, Purdue University College of Pharmacy, West Lafayette, Indiana; Jefferson Science Fellow, USAID Africa Health Bureau for Sustainable Development, Washington, D.C.; Adjunct Assistant Professor, Indiana University School of Medicine, Bloomington, Indiana; Visiting Lecturer, Moi University School of Medicine, Eldoret, Kenya
      View Biography

Learning Objectives
1. Recognize global trends in non-communicable diseases (NCDs) and the impact of biological, behavioral, and social determinants
2. Examine current regional and global initiatives for preventing and controlling NCDs in low and middle income countries (LMICs)
3. Describe funding opportunities for sustainable treatment of NCDs in resource-constrained settings
The Promise and Pitfalls of Technology in Addressing Noncommunicable Diseases in Developing Countries
3:00 PM

  • David R. Steeb, Pharm.D.Speaker: David R. Steeb, Pharm.D.
    Clinical Assistant Professor, Director of Global Engagement, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina

Learning Objectives
1. Recognize the impact of technology to improve health care delivery in low and middle income countries (LMICs).
2. Explain the mobile health and point-of-care (POC) testing currently being utilized to address non-communicable diseases (NCDs) in resource-constrained regions.
3. Evaluate challenges and future advances of these technologies to address NCDs.